首頁 > 市場調查報告書 > 醫療設備

泌尿科

市場調查報告書

商品編碼

1623323

泌尿外科器械市場：按手術類型、最終用戶應用和地區劃分，2024-2031 年

Urology Surgical Devices Market By Procedure Type, End User Application & Region for 2024-2031

出版日期: 2024年11月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

泌尿科器械市場評估，2024-2031

前列腺癌、腎結石和尿失禁等泌尿系統問題變得越來越普遍。隨著這些疾病變得越來越普遍，對更好的診斷和手術技術的需求將會增加，到 2024 年將達到 394.7 億美元，到 2031 年將達到 573.9 億美元。

此外，微創治療的趨勢和機器人輔助技術的引入正在透過提高手術精度、縮短恢復時間和改善患者治療結果來推動市場擴張。影像和設備材料的改進等技術突破透過提供更有效、侵入性更小的治療替代方案正在推動市場向前發展，預計 2024 年至 2031 年複合年增長率約為 4.79%。

泌尿外科手術器械市場定義/概述

泌尿外科手術器械是用於診斷、治療和管理涉及泌尿道和男性生殖系統的泌尿外科疾病的專用儀器和設備。這些設備包括微創手術器械、機器人輔助系統、診斷影像設備等。泌尿外科設備用於治療多種疾病，包括腎結石、攝護腺癌、尿失禁和膀胱疾病。這些設備使微創手術和傳統方法更加實用，從而改善患者的治療效果並縮短復原時間。由於機器人手術、改進的成像技術以及用於更好診斷和治療的智慧設備等技術進步，泌尿外科手術設備的未來看起來充滿希望。持續的技術創新透過提高準確性、減少侵入性和提高患者舒適度，擴大了這些設備治療複雜泌尿系統疾病的範圍和有效性。

老年人口的增加會推動泌尿外科手術器械市場嗎？

老年人口的增加可能會促進泌尿外科手術設備市場的擴張。隨著世界人口老化，良性前列腺增生（BPH）、尿失禁和腎結石等與年齡相關的泌尿系統疾病變得越來越常見。這些疾病在老年人中很常見，用於診斷和治療的泌尿外科設備的需求不斷增加。

在經濟方面，不斷增長的老年人口正在推動醫療保健支出的繁榮，包括對泌尿外科設備的投資。老年人更頻繁地需要醫療護理，導致醫療費用增加。這種人口結構的變化導致公共和私人醫療保健部門將更多資源投入泌尿外科手術中，從而導致手術器械銷售的增加。此外，對更先進、微創手術技術的需求正在增加製造商的市場潛力。這是因為醫療保健專業人員努力縮短老年患者的復健時間並取得更好的結果。

從技術上講，不斷增長的老年人口正在推動泌尿外科手術器械的創新，以滿足老年患者的獨特需求。微創手術、機器人輔助手術和先進的影像技術正在被用來提高老年患者的手術精度並減少併發症。隨著該行業適應人口老化，製造商正在投資開發尖端產品，以解決老年患者面臨的特定問題，例如虛弱和合併症。這種對技術改進的渴望可以改善患者的治療效果，並有助於泌尿外科手術設備市場的整體成長。

手術設備成本上升是否會阻礙泌尿外科手術器械市場的成長？

手術設備成本上升可能會阻礙泌尿外科手術設備產業的擴張。隨著先進泌尿外科手術器械成本的增加，醫療保健提供者面臨預算限制，這可能會限制他們採用新技術的能力。這對於醫療保健預算有限和對成本敏感的低收入者尤其重要。對這些小工具的支出增加可能會降低採用率，並限制對尖端設備的使用，從而阻礙整體市場的成長。

例如，2024 年 5 月，醫療成本研究所報告稱，機器人手術系統和先進影像設備等高端泌尿科技術的價格大幅上漲。報告稱，儘管這些技術提高了準確性和治療效果，但其高昂的成本給醫療機構帶來了財務壓力，尤其是那些不太富裕地區的醫療機構。這種經濟壓力可能會減緩新技術的採用並對市場成長產生負面影響。

然而，我們正在努力抵消成本增加的影響。2024 年 6 月，幾家主要泌尿設備製造商宣佈努力透過創造性的定價策略以及與醫療保健提供者的合作，使其產品更加實惠。這些舉措包括成本分攤計劃和可擴展的技術解決方案，旨在減少採用先進泌尿設備的財務障礙。儘管成本上升仍然是一個問題，但這些舉措預計將有助於平衡市場成長並增加先進泌尿外科技術的取得。

Urological problems include prostate cancer, kidney stones, and urine incontinence are becoming increasingly common. As these illnesses become more prevalent, there is a greater need for better diagnostic and surgical technology growth surpassing USD 39.47 Billion in 2024 and reachingUSD 57.39 Billion by 2031.

Furthermore, the trend to minimally invasive treatments and the incorporation of robotic-assisted technologies help to drive market expansion by improving surgical precision, shortening recuperation times, and improving patient outcomes. Technological breakthroughs, such as improvements in imaging and device materials, drive the market forward by providing more effective and less invasive treatment alternatives is expected to grow at aCAGR of about 4.79% from 2024 to 2031.

Urology Surgical Devices Market: Definition/ Overview

Urology surgical devices are specialized instruments and equipment used to diagnose, treat, and manage urological disorders involving the urinary tract and male reproductive system. These gadgets include instruments for minimally invasive surgery, robotic-assisted systems, and diagnostic imaging equipment. Urology surgical devices are used to treat a variety of conditions, including kidney stones, prostate cancer, urine incontinence, and bladder diseases. They make minimally invasive operations and traditional approaches more feasible, resulting in better patient outcomes and shorter recovery times. The future of urology surgical equipment seems promising, because to technological breakthroughs such as robotic surgery, improved imaging techniques, and smart devices for better diagnoses and treatment. Continued innovation strives to improve precision, reduce invasiveness, and increase patient comfort, hence broadening the applicability and effectiveness of these devices in treating complicated urological disorders.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Rising Geriatric Population Drive the Urology Surgical Devices Market?

The growing elderly population is likely to boost the expansion of the urology surgical devices market. As the world's population ages, age-related urological disorders such benign prostatic hyperplasia (BPH), urine incontinence, and kidney stones become more common. These disorders are more common in older persons, which increases the demand for diagnostic and therapeutic urological devices.

From an economic aspect, the growing elderly population is driving a boom in healthcare spending, including investments in urology surgical instruments. Older persons frequently require medical attention, which leads to increased healthcare costs. This demographic transition causes both the public and commercial healthcare sectors to devote more resources to urological surgeries, resulting in higher sales of surgical instruments. Furthermore, the demand for more advanced and minimally invasive surgical technologies increases market potential for manufacturers, as healthcare practitioners strive to give better outcomes with shorter recovery periods for senior patients.

Technologically, the growing elderly population drives innovation in urology surgical instruments to satisfy the specific needs of older patients. Minimally invasive procedures, robotic-assisted operations, and advanced imaging technologies are being used to increase precision and reduce problems in elderly patients' surgeries. As the industry adjusts to suit the aging population, manufacturers invest in the creation of cutting-edge products that address specific issues that older patients confront, such as frailty and comorbidities. This desire for technological improvement improves patient outcomes and contributes to the overall growth of the urology surgical equipment market.

Will Rising Surgical Device Cost Hinder the Growth of the Urology Surgical Devices Market?

Rising surgical device costs may represent a hindrance to the expansion of the urology surgical devices industry. As the cost of sophisticated urology surgical instruments rises, healthcare providers may confront budget constraints that limit their capacity to adopt new technologies. This is especially important in regions with limited healthcare budgets or in low-income communities where cost sensitivity is strong. Increased spending on these gadgets may result in slower adoption rates and impede overall market growth by limiting access to cutting-edge equipment.

For instance, in May 2024, the Healthcare Cost Institute reported a considerable increase in the pricing of high-end urological technology, such as robotic surgical systems and advanced imaging instruments. According to the report, while these technologies improve precision and outcomes, their high costs put a financial pressure on healthcare facilities, particularly those in less affluent communities. This financial pressure may cause a sluggish adoption of new technology, thereby harming market growth.

However, initiatives are underway to offset the effects of increased expenses. In June 2024, several major urological device makers announced attempts to make their products more affordable through creative pricing strategies and collaborations with healthcare providers. These efforts include cost-sharing schemes and scalable technological solutions that aim to reduce the financial barrier to adopting sophisticated urological devices. While rising costs are still a problem, these initiatives are projected to help balance market growth and increase access to sophisticated urology surgical technology.

Category-Wise Acumens

Will Rising Usage of Ureteroscopy Drive the Urology Surgical Devices Market?

The increasing use of ureteroscopy is projected to drive the urology surgical devices market significantly. Ureteroscopy is a minimally invasive treatment that diagnoses and treats ureter and kidney diseases such as stones, tumors, and strictures. Its growing popularity is largely due to the procedure's success in treating these problems with shorter recovery times and fewer complications than traditional surgical treatments. As more patients and healthcare providers realize the benefits of ureteroscopy, its popularity grows, resulting in growing demand for specialized ureteroscopic instruments.

In May 2024, Olympus Corporation announced the launching of its next-generation flexible ureteroscope, which is expected to provide greater picture quality and agility. This innovative gadget intends to improve procedure outcomes and patient comfort, reflecting the growing desire for ureteroscopy in clinical practice. The launch of such novel equipment contributes to the increased demand for ureteroscopy and drives the growth of the urology surgical devices market.

Furthermore, healthcare institutions and legislative improvements have helped to boost the number of preventive and diagnostic urological treatments performed. For instance, in July 2024, the American Urological Association (AUA) issued guidelines advocating ureteroscopy for specific cases of kidney stones and ureteral obstruction. This endorsement from a renowned professional association promotes the use of ureteroscopy, boosting market growth by increasing the number of procedures performed and stimulating demand for better ureteroscopic technology.

Lithotripsy is the fastest-growing segment due to its non-invasive nature and effectiveness in removing kidney stones, which has increased in popularity. The expansion is aided by technical advancements that improve the precision and efficiency of lithotripsy procedures, catering to a larger patient population seeking less intrusive treatment options.

Will Rising Cases of Urolithiasis (Kidney Stones) Drive the Growth of Urology Surgical Devices Market?

The increasing prevalence of Urolithiasis (kidney stones) is likely to cause considerable growth in the urology surgical device market. Kidney stones are a prevalent ailment that affects a big portion of the population, and their incidence is on the rise as a result of dietary changes, obesity, and dehydration. As the number of people diagnosed with kidney stones increases, so does the demand for efficient treatment alternatives, which drives the need for better urology surgical instruments.

Furthermore, the emphasis on early detection and preventative care is driving market growth. In July 2024, the American Urological Association (AUA) stressed the necessity of implementing improved diagnostic methods for early diagnosis of kidney stones, allowing for prompt and successful treatment. This endorsement leads to higher acceptance of urological devices designed for both diagnosis and treatment, which drives market growth as healthcare professionals engage in cutting-edge technologies to efficiently manage the growing incidence of urolithiasis.

Urinary incontinence is the fastest-growing area, thanks to increased awareness and advances in surgical procedures including implanted devices and neuromodulation therapies. The growing older population and improved diagnostic tools are driving strong growth in this category, as more patients seek effective urinary incontinence treatments.

Country/Region-wise

Will High Adoption Rate of New Technologies in North America Drive the Urology Surgical Devices Market?

North America's strong acceptance rate of new technologies is projected to significantly drive the urological surgical devices market. North America, notably the United States and Canada, has a well-established healthcare infrastructure and a strong commitment to incorporating innovative technologies into clinical practice. The region's commitment to innovation and research results in rapid adoption of cutting-edge surgical equipment, boosting market growth by fulfilling the growing need for innovative and effective urological treatments.

In April 2024, the American Urological Association (AUA) published a report on the increasing usage of robotic-assisted surgical equipment for urological surgeries in North America. This survey noted a significant growth in the usage of these systems, which are driven by their capacity to provide more precision and better patient outcomes. The AUA's findings highlight the region's excitement for adopting new technology, which stimulates demand for innovative urology surgical instruments and propels market growth.

Will Rising Awareness of Urological Conditions in Asia-Pacific Propel the Urology Surgical Devices Market?

The growing awareness of urological problems in the Asia-Pacific region is likely to drive the urology surgical instruments market. As healthcare knowledge grows, more people seek diagnosis and treatment for urological problems, increasing the demand for improved surgical technologies. The increased emphasis on education and public health initiatives is helping to eliminate the stigma associated with certain disorders and promote early diagnosis, resulting in higher market growth.

For instance, in June 2024, the World Health Organization (WHO) announced a new program to raise awareness of urological health issues throughout the Asia-Pacific area. This campaign includes educational initiatives and screenings, which are expected to drive up demand for urological diagnostics and surgical technologies. The WHO's emphasis on improving access to care and early intervention is predicted to boost market growth by increasing the number of procedures performed and the use of new technology.

In July 2024, Medtronic also announced a strategic agreement with local health authorities in Asia-Pacific to increase the availability of its urological surgical equipment in emerging areas. This collaboration intends to meet the growing need for innovative surgical solutions in these regions, and it is projected to increase market penetration. This approach coincides with increased awareness and growing healthcare demands in the region by improving the availability of high-quality urological equipment and supporting local healthcare infrastructure, driving market expansion even further.

Competitive Landscape

The competitive landscape of the urology surgical devices market is characterized by rapid technological advancements and a focus on innovation. Companies are continuously developing new devices with enhanced precision, minimally invasive techniques, and improved patient outcomes. The market sees a mix of large multinational corporations and specialized firms, all striving to differentiate themselves through product differentiation, strategic partnerships, and expanding their product portfolios to address a broad range of urological conditions. Additionally, increasing adoption of robotic-assisted surgeries and advancements in imaging technologies are shaping the competitive dynamics.

Some of the prominent players operating in the urology surgical devices market include:

Olympus

Boston Scientific

Medtronic

Teleflex

Karl Storz

Coloplast

Conmed

Stryker

Cook Medical

Latest Developments

In May 2024, Boston Scientific purchased a urology device startup that offers new, minimally invasive therapies for urine incontinence. This acquisition will enable Boston Scientific to broaden its product offerings and incorporate cutting-edge technologies into its urology portfolio.

In July 2024, Fresenius Medical Care developed an improved dialysis device for urological applications, aimed at better patient treatment of chronic kidney disease. This device incorporates advanced filtration technology to help address urological issues caused by kidney disease.

In March 2024, Coloplast developed a novel urological catheter with enhanced materials and design characteristics to reduce infection rates and improve patient comfort. The catheter is intended to enhance the overall experience for patients who require long-term catheterization.